MedCity News

MARCH 13, 2023

Price transparency has come a long way over the past couple of years, with insurance companies and hospitals now required to publicly disclose their prices. The more pressing issue is that there is no mechanism in place to make this information easily digestible, personalized to each patient, and placed in context with competitors’ prices.

Doctors 241

Doctors Prescription Insurance Patients 241

MedCity News

JULY 21, 2023

What we need to overcome adherence challenges is a digitally enabled marketplace of options that can be personalized to the patient and the context of their specific condition, pharmacy preference and ability to pay.

Prescription 246

Prescription Patients Biopharma Medical 246

MedCity News

APRIL 2, 2023

Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.

FDA 307

FDA Prescription Biopharma Pharma 307

MedCity News

JULY 28, 2022

Prescription digital therapeutics can and should be considered as part of type 2 diabetes therapies. While pharmaceuticals are a critical piece of the treatment landscape for type 2 diabetes, they have been the exclusive and de-facto first-line treatment for too long.

Pharmaceutical 301

Pharmaceutical Prescription Biopharma 301

MedCity News

APRIL 10, 2023

Pear Therapeutics’ Chapter 11 bankruptcy filing follows three corporate restructurings and the inability to secure additional financing to support commercialization of its FDA-cleared prescription digital therapeutics. An auction of Pear’s assets is expected to happen in early May.

Prescription 284

Prescription FDA Biopharma 284

MedCity News

DECEMBER 8, 2023

Prescriptions for GLP-1s are soaring, but fewer than a third of people prescribed the costly drugs will continue taking them one year later without personalized support.

Prescription 293

Prescription Biopharma 293

MedCity News

OCTOBER 24, 2022

Specialty carve outs that move specialty drugs away from traditional prescription drug management to a pharmacy benefit administrator (PBA) or specialty administrator will continue and likely to provide cost savings.

Prescription 273

Prescription Pharmaceutical Patients Management 273

MedCity News

JULY 13, 2023

FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.

FDA 246

FDA Prescription Healthcare Healthcare 246

MedCity News

MARCH 19, 2023

Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking strategic alternatives for the business. Prospective buyers can pick up Pear’s FDA-cleared products for substance use disorder, opioid use disorder, and insomnia.

Prescription 246

Prescription Prospecting FDA Biopharma 246

MedCity News

DECEMBER 27, 2022

Earlier this year, CMS implemented a new Level II Healthcare Common Procedure Coding System (HCPCS) code for “prescription digital behavioral therapy,” which makes it easier for commercial and Medicaid plans to cover these therapies. Additionally.

Healthcare 244

Healthcare Healthcare Prescription Biopharma 244

MedCity News

FEBRUARY 4, 2024

In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year. By enforcing transparency, PBMs would need to release detailed information on prescription drug spending. 2024 stands at a critical juncture in the battle against soaring pharmacy costs. Transparency and reporting requirements.

Prescription 298

Prescription Networking Management Pharmaceutical 298

pharmaphorum

JUNE 27, 2022

The bolt-on deal comes shortly after Ipsen announced plans to sell its consumer health business for around €350 million, leaving it as a pure-play prescription pharma operating in the cancer, rare diseases and neuroscience categories. The post Ipsen beefs up in oncology, buying US biopharma Epizyme appeared first on.

Biopharma 110

Biopharma Sales Prescription FDA 110

MedCity News

AUGUST 27, 2023

doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events. The Walt Disney Company excels in designing exceptional service because they are hyper-focused on listening, tracking, designing, and measuring the experiences of guests visiting their properties.

Healthcare 242

Healthcare Healthcare Prescription Doctors 242

MedCity News

JULY 11, 2023

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.

FDA 189

FDA Prescription Biopharma Medical 189

MedCity News

JUNE 12, 2023

Bringing the very first prescription digital therapeutic (PDT) to market in 2017, Pear Therapeutics went above and beyond to follow suggested regulatory guidelines, obtained Food & Drug Administration (FDA) clearance, and provided solid clinical study evidence. Photo: Bulat Silvia, Getty Images

Food and Drug Administration 260

Food and Drug Administration Prescription Government FDA 260

pharmaphorum

DECEMBER 18, 2022

The clerical overhead of enrolment forms navigated over fax and phone calls fails to deliver on the promise, resulting in lower-than-expected prescription volumes and lacklustre adoption among prescribers. The post Access solutions: the missing link that prevents biopharma innovation from reaching patients appeared first on.

Biopharma 98

Biopharma Patients Prescription Medical 98

PM360

FEBRUARY 1, 2024

Embarking on the journey from product development to market success in the biopharma industry is no small feat. The landscape is highly competitive with new prescription medications launching worldwide each year. However, this journey is fraught with challenges as revealed by an in-depth analysis.

Biopharma 59

Biopharma Competition Prescription Marketing 59

Pharmaceutical Commerce

FEBRUARY 4, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Prescription 69

Prescription Distribution Biopharma Marketing 69

pharmaphorum

JULY 18, 2022

The separation leaves GSK as a biopharma and vaccines pure-play that chief executive Emma Walmsley has said will deliver £33 billion in annual revenues by 20231, up from £24.5 Last year, GSK rejected a $68 billion bid from Unilever for the consumer health operations, saying the offer “fundamentally undervalued” the business.

Biopharma 124

Biopharma Sales Prescription Pharma 124

Pharmaceutical Commerce

DECEMBER 6, 2023

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

Biopharma 65

Biopharma Prescription Patients 65

MedCity News

NOVEMBER 11, 2024

Top challenges impacting specialty pharmacy outcomes, and how health systems may achieve efficiencies and enhance performance for optimal outcomes. The post An Integrated Approach to Optimizing Specialty Pharmacy and Accelerating Performance appeared first on MedCity News.

Prescription 284

Prescription Pharmaceutical Biopharma 284

Zymewire

SEPTEMBER 15, 2023

The bill also enables Medicare to negotiate prescription drug prices and extends the Affordable Care Act through 2025. Signed into law in August 2022, the Inflation Reduction Act (IRA) was designed to fight inflation, invest in domestic (US) energy production & manufacturing, and reduce carbon emissions.

Biopharma 52

Biopharma Prescription Manufacturing 52

MedCity News

JUNE 16, 2023

The earliest higher-profile digital therapeutic leaders focused on mental and behavioral health with some earning Food and Drug Administration approval for managing conditions such as attention-deficit and hyperactivity disorder, substance-use disorder, and insomnia using a prescription-level app alone or in conjunction with pharmacologic therapy.

Pharma 306

Pharma Food and Drug Administration Recruitment Patients 306

PM360

MAY 23, 2024

Bryan Johnson Senior Director, Product Management, Compass Prescriber Veeva Systems Paving the Way to Faster Treatment Starts Bryan’s exposure to life sciences started at a young age, watching his father’s career at companies like Johnson & Johnson and emerging biopharmas. As rare diseases affect about 1 in 10 people in the U.S.,

Retail 52

Retail Biopharma Prescription Healthcare Provider 52

MedCity News

DECEMBER 22, 2024

As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond. The post 2025 and Beyond: Key Trends to Watch in Pharmacy appeared first on MedCity News.

Prescription 293

Prescription Pharmaceutical Biopharma Medical 293

pharmaphorum

JUNE 12, 2017

Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans.

Marketing 52

Marketing Engineering Biopharma Prescription 52

MedCity News

SEPTEMBER 9, 2024

Losing these retail medication outlets creates more than just pharmacy deserts. In many low-income and underserved areas, drugstores also serve as grocery stores and hubs for essential services, and hence their closures mean communities lose crucial access points for a variety of goods and services.

Retail 300

Retail Medical Prescription Management 300

pharmaphorum

OCTOBER 24, 2022

Sumitomo and its subsidiary Sumitovant Biopharma initially offered $22.75 At the time, Myovant said Myfembree was the market leader in the oral GnRH category with a 51% share in new prescriptions for uterine fibroids that was keeping it ahead of main rival AbbVie/Neurocrine Biosciences’ Orilissa/Oriahnn (elagolix).

Biopharma 75

Biopharma Marketing Pharma Prescription 75

MedCity News

JANUARY 25, 2023

As healthcare organizations comply with the federal EPCS mandate, artificial intelligence and digital identity technologies should be utilized to detect, reduce, and remediate drug diversion.

Healthcare 284

Healthcare Healthcare Electronics Prescription 284

MedCity News

SEPTEMBER 15, 2024

To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.

Medical 290

Medical Healthcare Healthcare Patients 290

pharmaphorum

DECEMBER 23, 2022

With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.

Marketing 105

Marketing Sales Medical Patients 105

MedCity News

AUGUST 29, 2023

HHS released the first 10 drugs selected for the Medicare Drug Price Negotiation Program. These drugs include Eliquis, Jardiance and Xarelto. Under the program, the federal government will be able to negotiate the price for selected drugs for the first time.

Government 282

Government Prescription Biopharma 282

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

Pharmaceutical Technology

JANUARY 4, 2023

Ondansetron hydrochloride CR is under clinical development by RedHill Biopharma and currently in the Phase II and Phase III in clinical pathway. RedHill Biopharma overview RedHill Biopharma (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer.

Biopharma 40

Biopharma Prescription Pharmaceutical 40

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. Total revenues came in at £6.9 billion ($8.3 GSK has already made moves in this direction this year with deals to buy cancer specialist Sierra Oncology for $1.9 billion.

Sales 52

Sales Biopharma Medicine Prescription 52

Pharmaceutical Technology

NOVEMBER 4, 2022

For example, digital twins of pharmaceutical supply chains can predict bottlenecks and give suggestions for how to respond using prescriptive AI. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

pharmaphorum

SEPTEMBER 26, 2022

Mackay has been CFO at the UK big pharma since the beginning of 2019, and is departing the company shortly after the spin-out of consumer health business Haleon in order to focus on prescription drugs and vaccines. billion and $1.9 billion, respectively.

Management 52

Management Pharma Biopharma Prescription 52